Publication

A glimpse into the future of model-informed drug discovery and development

Explore the future of Model-Informed Drug Development (MIDD), including advances in pharmacometrics, PBPK, QSP, precision…

Certara2026 年 8 月 28 日

Publication

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

Explore how model-based tumor growth inhibition metrics can support earlier Go/No-Go decisions and pivotal trial…

Certara2026 年 8 月 28 日

Case Study

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

Learn how Model-based meta-analysis (MBMA) helped optimize Phase 3 trial design, dose selection, and development…

Danielle Pillsbury2026 年 8 月 28 日

Blog

The five drug development questions that bring sponsors to pharmacometrics

Sponsors rarely come to pharmacometrics because they need a model. They come with a development…

Rik de Greef2026 年 8 月 24 日

Webinar

Beyond Trial and Error: Model-Informed Formulation Development in Practice

Siri Kalyan Chirumamilla2026 年 8 月 24 日

Fact Sheet

Model-Based Meta-Analysis (MBMA): Real-World Examples

See real-world examples of how model-based meta-analysis (MBMA) uses existing clinical evidence to predict trial…

Certara2026 年 8 月 24 日

Blog

MBMA data curation: How AI and expert meta-analysts get it right, fast

In MBMA, the data layer is the real bottleneck. See how AI and expert meta-analysts…

Matt Zierhut, PhD MBA2026 年 8 月 14 日

Webinar

Transforming drug interaction evaluation workflows with DIDB

Ichiko Petrie, PharmD2026 年 8 月 14 日

Blog

A model-informed approach to radioligand therapy dosing under Project Optimus

Explore how targeted radionuclide therapy dosing uses QSP, biologically effective dose (BED), and exposure-response modeling…

Hunter Stephens, PhD2026 年 8 月 13 日

Live Events

Tailwinds for MIDD: What to Know About the Changing Regulatory Landscape

2026 年 9 月 30 日 - 11:30 PM – 2:00 PM

Certara2026 年 8 月 12 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

模型引导的药物开发

A glimpse into the future of model-informed drug discovery and development

Refinement of Operating Characteristics for Model-Based TGI Metrics Decision Support to Ungate a Pivotal Trial in Oncology

De-Risking Phase 3 Rheumatoid Arthritis Trials with Model-Based Meta-Analysis (MBMA)

The five drug development questions that bring sponsors to pharmacometrics

Beyond Trial and Error: Model-Informed Formulation Development in Practice

Model-Based Meta-Analysis (MBMA): Real-World Examples

MBMA data curation: How AI and expert meta-analysts get it right, fast

Transforming drug interaction evaluation workflows with DIDB

A model-informed approach to radioligand therapy dosing under Project Optimus

Tailwinds for MIDD: What to Know About the Changing Regulatory Landscape

订阅时事通讯

快捷链接

解决方案

联系我们